ShockWave Medical, Inc.
SWAV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $218,805 | $202,979 | $186,020 | $180,165 |
| % Growth | 7.8% | 9.1% | 3.2% | – |
| Cost of Goods Sold | $28,207 | $25,316 | $24,513 | $24,493 |
| Gross Profit | $190,598 | $177,663 | $161,507 | $155,672 |
| % Margin | 87.1% | 87.5% | 86.8% | 86.4% |
| R&D Expenses | $44,466 | $42,321 | $39,526 | $36,829 |
| G&A Expenses | $29,233 | $24,879 | $21,451 | $29,731 |
| SG&A Expenses | $103,725 | $92,060 | $78,358 | $86,469 |
| Sales & Mktg Exp. | $74,492 | $67,181 | $56,907 | $56,738 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $148,191 | $133,081 | $117,884 | $123,298 |
| Operating Income | $42,407 | $44,582 | $43,623 | $32,374 |
| % Margin | 19.4% | 22% | 23.5% | 18% |
| Other Income/Exp. Net | $7,592 | $10,878 | $1,457 | $630 |
| Pre-Tax Income | $49,999 | $55,460 | $45,080 | $33,004 |
| Tax Expense | -$5,347 | $11,155 | $10,094 | $4,142 |
| Net Income | $55,346 | $44,305 | $34,986 | $28,862 |
| % Margin | 25.3% | 21.8% | 18.8% | 16% |
| EPS | 1.48 | 1.2 | 0.95 | 0.79 |
| % Growth | 23.3% | 26.3% | 20.3% | – |
| EPS Diluted | 1.44 | 1.16 | 0.92 | 0.76 |
| Weighted Avg Shares Out | 37,285 | 36,930 | 36,797 | 36,663 |
| Weighted Avg Shares Out Dil | 38,472 | 38,159 | 38,197 | 38,226 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,318 | $0 | $2,509 | $810 |
| Interest Expense | $2,943 | $2,950 | $2,509 | $810 |
| Depreciation & Amortization | $3,109 | $3,075 | $3,009 | $2,566 |
| EBITDA | $56,051 | $61,485 | $50,598 | $36,380 |
| % Margin | 25.6% | 30.3% | 27.2% | 20.2% |